These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. High-dose intravenous immune globulin for stiff-person syndrome. Solaro C N Engl J Med; 2002 May; 346(22):1747-8; author reply 1747-8. PubMed ID: 12041528 [No Abstract] [Full Text] [Related]
8. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases]. Klein M; Kaminsky P; Duc M Therapie; 1993; 48(2):97-103. PubMed ID: 8351694 [TBL] [Abstract][Full Text] [Related]
9. Important drug warning: Immune Globulin Intravenous (human) (IGIV) products. Epstein JS; Zoon KC Neonatal Netw; 2000 Mar; 19(2):60-2. PubMed ID: 11949001 [No Abstract] [Full Text] [Related]
10. Safety and tolerability of an intravenous immune globulin at various concentrations in 5% dextrose injection or sterile water for injection. Miller KB; Schenkein DP; Wasserman RL Clin Pharm; 1992 Jul; 11(7):628-31. PubMed ID: 1617914 [No Abstract] [Full Text] [Related]
12. Home infusion of intravenous immune globulin in human immunodeficiency virus--infected children. Poole JK J Intraven Nurs; 1993; 16(3):195. PubMed ID: 8515340 [No Abstract] [Full Text] [Related]
13. Is pertussis immune globulin efficacious for the treatment of hospitalized infants with pertussis? No answer yet. Halperin SA; Vaudry W; Boucher FD; Mackintosh K; Waggener TB; Smith B; Pediatr Infect Dis J; 2007 Jan; 26(1):79-81. PubMed ID: 17195712 [TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of intravenous immunoglobulins. Martin TD Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():514-20. PubMed ID: 10689502 [No Abstract] [Full Text] [Related]
15. Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders. Grillo JA; Gorson KC; Ropper AH; Lewis J; Weinstein R Neurology; 2001 Nov; 57(9):1699-701. PubMed ID: 11706114 [TBL] [Abstract][Full Text] [Related]
17. [Known and potential risks related to the use of high dose intravenous immunoglobulins]. Bussel A Ann Dermatol Venereol; 1997; 124(5):381-3. PubMed ID: 9739894 [No Abstract] [Full Text] [Related]
18. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura. Ruggeri M; Castaman G; De Nardi G; Rodeghiero F Haematologica; 1993; 78(5):338-9. PubMed ID: 8314166 [TBL] [Abstract][Full Text] [Related]
19. Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome? Federici AB; Rossi V; Sacchi E; Franchini M Blood Transfus; 2012 Jul; 10(3):402-3; author reply 404-5. PubMed ID: 22244008 [No Abstract] [Full Text] [Related]
20. Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases. Berger M; Pinciaro PJ; J Clin Immunol; 2004 Jul; 24(4):389-96. PubMed ID: 15163895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]